Mepolizumab
Also known as Nucala (us)
Mepolizumab injection is used alone or with other medications to treat asthma and chronic obstructive pulmonary disease (COPD, a group of diseases that affect the lungs and airways) to treat chronic rhinosinusitis with nasal polyps (a condition where nasal cavity and sinuses become inflammed for 12…
Based on 30 units per month. US $3,679.11 vs India $751.28 per unit.
The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.
- Medicine savings over 6 months
- $527,009
- Estimated travel cost
- − $2,300
- Net savings after travel
- $524,709
Even after travel, you could come out ahead by about $524,709.
Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.
Mepolizumab is filled about 72.3K times a year under Medicare Part D. At the prices above, that works out to roughly:
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.